ASX - By Stock
|
DRO |
Re:
Huge in the pipelines
|
|
TimothyTMLim
|
6 |
1.9K |
0 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
6
|
1.9K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
TimothyTMLim
|
118 |
59K |
3 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
118
|
59K
|
3
|
|
ASX - By Stock
|
DRO |
Re:
DRO systems are widely considered to be the best available - well over 1000 individual systems in Ukraine
|
|
TimothyTMLim
|
17 |
6.8K |
0 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
17
|
6.8K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
DRO systems are widely considered to be the best available - well over 1000 individual systems in Ukraine
|
|
TimothyTMLim
|
17 |
6.8K |
0 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
17
|
6.8K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
DRO systems are widely considered to be the best available - well over 1000 individual systems in Ukraine
|
|
TimothyTMLim
|
17 |
6.8K |
1 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
17
|
6.8K
|
1
|
|
ASX - By Stock
|
DRO |
Re:
DRO systems are widely considered to be the best available - well over 1000 individual systems in Ukraine
|
|
TimothyTMLim
|
17 |
6.8K |
2 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
17
|
6.8K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Update Webcast
|
|
TimothyTMLim
|
49 |
13K |
4 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
49
|
13K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
FDA Guidelines on the Provision of Information to the News Media
|
|
TimothyTMLim
|
42 |
33K |
4 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
42
|
33K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
70% (!) of their 90 patients with severe to moderate COVID-19 infections have been taken off ventilators
|
|
TimothyTMLim
|
75 |
43K |
1 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
75
|
43K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
70% (!) of their 90 patients with severe to moderate COVID-19 infections have been taken off ventilators
|
|
TimothyTMLim
|
75 |
43K |
1 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
75
|
43K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
100% approval rate by FDA, and potentially the only Covid19 treatment
|
|
TimothyTMLim
|
5 |
3.5K |
0 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
5
|
3.5K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
100% approval rate by FDA, and potentially the only Covid19 treatment
|
|
TimothyTMLim
|
5 |
3.5K |
16 |
16/08/20 |
16/08/20 |
ASX - By Stock
|
5
|
3.5K
|
16
|
|
ASX - By Stock
|
MSB |
100% approval rate by FDA, and potentially the only Covid19 treatment
|
|
TimothyTMLim
|
5 |
3.5K |
52 |
16/08/20 |
16/08/20 |
ASX - By Stock
|
5
|
3.5K
|
52
|
|
ASX - By Stock
|
MSB |
Re:
Ann: ODAC Votes in Favor of Remestemcel-L for GvHD
|
|
TimothyTMLim
|
142 |
66K |
6 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
142
|
66K
|
6
|
|
ASX - By Stock
|
JMS |
Re:
Ann: 2020 Annual General Meeting Presentation
|
|
TimothyTMLim
|
14 |
3.9K |
1 |
09/07/20 |
09/07/20 |
ASX - By Stock
|
14
|
3.9K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Clarification on Initial US Distribution Agreement
|
|
TimothyTMLim
|
76 |
28K |
2 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
76
|
28K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Clarification on Initial US Distribution Agreement
|
|
TimothyTMLim
|
76 |
28K |
3 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
76
|
28K
|
3
|
|
ASX - By Stock
|
FFM |
Re:
Ann: High-Grade Gold JORC Inferred Resource 830,000oz @ 11.6 g/t
|
|
TimothyTMLim
|
459 |
161K |
5 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
459
|
161K
|
5
|
|
ASX - By Stock
|
ALK |
Re:
Ann: High Grades Confirm Continuity at Roswell and San Antonio
|
|
TimothyTMLim
|
60 |
29K |
2 |
22/06/20 |
22/06/20 |
ASX - By Stock
|
60
|
29K
|
2
|
|
ASX - By Stock
|
NVX |
Re:
Ann: Single Crystal Cathode Manufacturing Patented by NOVONIX
|
|
TimothyTMLim
|
128 |
55K |
0 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
128
|
55K
|
0
|
|
ASX - By Stock
|
NVX |
Re:
Ann: Single Crystal Cathode Manufacturing Patented by NOVONIX
|
|
TimothyTMLim
|
128 |
55K |
1 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
128
|
55K
|
1
|
|
ASX - By Stock
|
E25 |
Re:
Ann: PFS Highlights Robust, Short Lead Time Start-up Opportunity
|
|
TimothyTMLim
|
234 |
67K |
2 |
19/05/20 |
19/05/20 |
ASX - By Stock
|
234
|
67K
|
2
|
|
ASX - By Stock
|
MYR |
Re:
Ann: COVID-19 Business Update
|
|
TimothyTMLim
|
157 |
69K |
1 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
157
|
69K
|
1
|
|
ASX - By Stock
|
MYR |
Re:
Ann: COVID-19 Business Update
|
|
TimothyTMLim
|
157 |
69K |
3 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
157
|
69K
|
3
|
|
ASX - By Stock
|
AQG |
Re:
Q1 Report released tomorrow night
|
|
TimothyTMLim
|
21 |
4.8K |
1 |
04/05/20 |
04/05/20 |
ASX - By Stock
|
21
|
4.8K
|
1
|
|
ASX - By Stock
|
A2M |
Re:
Demand update...
|
|
TimothyTMLim
|
31 |
9.4K |
1 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
31
|
9.4K
|
1
|
|
ASX - By Stock
|
A2M |
Re:
Demand update...
|
|
TimothyTMLim
|
31 |
9.4K |
0 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
31
|
9.4K
|
0
|
|
ASX - By Stock
|
A2M |
Demand update...
|
|
TimothyTMLim
|
31 |
9.4K |
3 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
31
|
9.4K
|
3
|
|
ASX - By Stock
|
DCN |
Re:
Ann: Half Year Financial Statements
|
|
TimothyTMLim
|
14 |
8.8K |
0 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
14
|
8.8K
|
0
|
|
ASX - By Stock
|
1MC |
Re:
Ann: New Financing Package
|
|
TimothyTMLim
|
127 |
71K |
8 |
08/03/20 |
08/03/20 |
ASX - By Stock
|
127
|
71K
|
8
|
|
ASX - By Stock
|
1MC |
Re:
Ann: Production Update
|
|
TimothyTMLim
|
320 |
161K |
0 |
24/12/19 |
24/12/19 |
ASX - By Stock
|
320
|
161K
|
0
|
|
ASX - By Stock
|
1MC |
Re:
Ann: Production Update
|
|
TimothyTMLim
|
320 |
161K |
0 |
24/12/19 |
24/12/19 |
ASX - By Stock
|
320
|
161K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DMC Completes Final Review of Phase 3 Heart Failure Trial
|
|
TimothyTMLim
|
73 |
49K |
7 |
20/12/19 |
20/12/19 |
ASX - By Stock
|
73
|
49K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DMC Completes Final Review of Phase 3 Heart Failure Trial
|
|
TimothyTMLim
|
73 |
49K |
1 |
19/12/19 |
19/12/19 |
ASX - By Stock
|
73
|
49K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DMC Completes Final Review of Phase 3 Heart Failure Trial
|
|
TimothyTMLim
|
73 |
49K |
9 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
73
|
49K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DMC Completes Final Review of Phase 3 Heart Failure Trial
|
|
TimothyTMLim
|
73 |
49K |
22 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
73
|
49K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CHF P3 Trial Accrues Sufficient Primary Endpoint Events
|
|
TimothyTMLim
|
27 |
13K |
0 |
17/12/19 |
17/12/19 |
ASX - By Stock
|
27
|
13K
|
0
|
|
ASX - By Stock
|
A2M |
Re:
Ann: MD & CEO
|
|
TimothyTMLim
|
351 |
146K |
5 |
10/12/19 |
10/12/19 |
ASX - By Stock
|
351
|
146K
|
5
|
|
ASX - By Stock
|
DCN |
Re:
Ann: Annual Financial Statements
|
|
TimothyTMLim
|
30 |
16K |
3 |
13/09/19 |
13/09/19 |
ASX - By Stock
|
30
|
16K
|
3
|
|
ASX - By Stock
|
AKE |
Re:
Ann: Half Yearly Report and Accounts
|
|
TimothyTMLim
|
24 |
6.3K |
1 |
03/03/16 |
03/03/16 |
ASX - By Stock
|
24
|
6.3K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Potted Summary
|
|
TimothyTMLim
|
20 |
10K |
3 |
17/02/16 |
17/02/16 |
ASX - By Stock
|
20
|
10K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Presentation
|
|
TimothyTMLim
|
32 |
10K |
0 |
17/02/16 |
17/02/16 |
ASX - By Stock
|
32
|
10K
|
0
|
|
Commodities
|
AKE |
Lithium
|
|
TimothyTMLim
|
1 |
818 |
3 |
17/02/16 |
17/02/16 |
Commodities
|
1
|
818
|
3
|
|
ASX - General
|
|
Re:
Value Investment
|
|
TimothyTMLim
|
2 |
1.7K |
0 |
15/02/16 |
15/02/16 |
ASX - General
|
2
|
1.7K
|
0
|
|
ASX - General
|
|
Value Investment
|
|
TimothyTMLim
|
2 |
1.7K |
0 |
14/02/16 |
14/02/16 |
ASX - General
|
2
|
1.7K
|
0
|
|
ASX - By Stock
|
GXY |
Re:
Quarterly Report
|
|
TimothyTMLim
|
62 |
15K |
2 |
28/01/16 |
28/01/16 |
ASX - By Stock
|
62
|
15K
|
2
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Quarterly Activities Report
|
|
TimothyTMLim
|
118 |
52K |
4 |
28/01/16 |
28/01/16 |
ASX - By Stock
|
118
|
52K
|
4
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Quarterly Activities Report
|
|
TimothyTMLim
|
118 |
52K |
2 |
28/01/16 |
28/01/16 |
ASX - By Stock
|
118
|
52K
|
2
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Quarterly Activities Report
|
|
TimothyTMLim
|
118 |
52K |
3 |
28/01/16 |
28/01/16 |
ASX - By Stock
|
118
|
52K
|
3
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Quarterly Activities Report
|
|
TimothyTMLim
|
118 |
52K |
2 |
27/01/16 |
27/01/16 |
ASX - By Stock
|
118
|
52K
|
2
|
|